| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |